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Presentation of Case
A 46-year-old male shepherd presented
with a mildly painful mass 4.5 cm in
diameter localized at the right groin and
thigh, diffuse edema involving the right leg
lasting for 2 weeks, and fever. The patient
had had eight previous operations for
diffuse hydatidosis with reported intraper-
itoneal seeding, but further information
was unavailable.
Laboratory tests are shown in Table 1.
An abdominal ultrasound (US) and a
Doppler US of the right leg detected the
presence of multiple and partially confluent
cysts localized up to the Scarpa’s triangle. A
computed tomography (CT) scan detected
a multi-cystic 18-cm mass originating from
the psoas muscle (Figure 1, I and II). Other
cysts were localized deeply and behind the
muscular aponeurotic plane of the femoral
quadriceps and abductor muscles (Figure 1,
III and IV). All these findings were sug-
gestiveofdiffusehydatidosisandthe patient
was promptly operated on with a muscle-
sparing approach, for which a written
consent was obtained.
Piperacillin/tazobactam was adminis-
tered from the date of admission to the
day of surgery. Preoperative prophylaxis
with benzimidazole derivatives was not
performed due to the extent of the disease,
the history of recurrences, and the need to
perform the operation promptly to reduce
the symptoms.
At surgery, the retroperitoneum was
accessed and tissues surrounding the cysts
were covered with sponges soaked with
hypertonic saline. The cystic content was
evacuated and the interior of the cyst was
repeatedly washed with protoscolicides.
Due to the tight adhesions with the peri-
toneal sac, only the lateral-lower portion
of the cystic wall could be resected. No
daughter cyst was found. Subsequently,
the right thigh was anteriorly incised and
the cysts were evacuated. The washing
treatment was repeated but extensive resec-
tion was avoided to prevent any risk of
unnecessary damage.
Histopathological examination did not
detect viable protoscolices and routine
cultures performed to individuate other
pathogens were negative.
A CT scan performed before discharge
showed the integrity of the psoas muscle
(Figure 2, I and II) and the lack of residual
cysts in the thigh with conservation of the
muscular structures (Figure 2, III and IV).
The patient was discharged after 11 days
with 6 months of administration of
mebendazole. Further investigations could
not be performed because the patient
missed the planned follow-up.
Case Discussion
In secondary hydatidosis, whose report-
ed incidence is between 1.1% and 25%
[1], muscle involvement may represent a
recurrence of previously treated disease
[2]. The pathogenesis of this condition is
different than primary hydatidosis, being
related to the spilling of the cystic contents
during a previous operation [1], together
with the lack of post-operative administra-
tion of benzimidazoles [3,4] and the lack
of follow-up.
Hydatid cysts of the psoas and thigh are
reported very rarely [2,5–15]. Symptoms
aregenerallyrelated tocyst’sdimension and
location [16], and may include infection
withfistulizationinsurroundingorgans,and
allergic reactions including anaphylactic
shock.
Different types of serological tests may
help in diagnosis [8]. In our case, no
serological test was performed due to the
strong clinical evidence related to patient’s
previous history and because of the need
for prompt treatment.
US represents the preferred diagnostic
method [9,10]. CT is performed in cases
of indeterminate US findings or negative
immunological tests. Large dimensions,
daughter cysts, and increased density of
the hydatid membrane are pathogno-
monic [8]. Magnetic resonance imaging
may clarify the diagnosis in some cases
[11].
Medical therapy with a benzimidazole
derivative is preferable whenever there is
multi-organ involvement or when patients
are not fit for surgery [9]. Although pre-
surgical use of benzimidazoles may reduce
the risk of recurrence and facilitate the
operation, neither the required duration of
such treatment, nor its efficacy, have been
documented [17]. We decided not to
administer pre-operative albendazole and
to operate 1 week later, as suggested by
another study [18]. Following surgery, we
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Learning Points
N Psoas and thigh, although rare localizations, could represent the site of primary
or secondary hydatidosis.
N Muscular hydatidosis should always be considered in patients with previous
history of such a disease, especially in cases of previous surgical dissemination.
N A muscle- or nerve-sparing attempt should always be performed in cases of
wide diffusion as well.
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administration of benzimidazoles [17].
Abnormalities in liver function, leuco-
penia and alopecia are side effects of the
benzimidazoles [19]. Alopecia seems to be
more frequently described after albenda-
zole administration [20]. The onset of this
complication induced our patient to dis-
continue the previous postoperative ther-
apy and not to restart the administration
of albendazole as suggested, so mebenda-
zole was proposed as the only chance to
prevent further recurrences.
The treatment of choice is complete
surgical excision of the cyst and irrigation
of the surrounding tissues with hypertonic
saline. World Health Organization guide-
lines suggest several specific approaches
for classic hydatidosis, but there is no
mention regarding unusual localizations
[17]. For cysts localized in the psoas
muscle, the extraperitoneal approach rep-
resents the safest access to avoid peritoneal
dissemination [9,10]. The cysts should be
removed without sacrificing any organ,
but sometimes it is impossible because of
the involvement of several organs or vital
structures [7,14]. Partial perycistectomy
and cyst drainage seems to be the best
approach due to its minimal invasiveness,
effectiveness, and tolerability [15].
An alternative to surgery is the US-
guided cyst puncture and injection of
protoscolicides (puncture, aspiration, in-
jection, and reaspiration [PAIR]), indicat-
ed for inoperable patients [17] and in cases
of relapse after surgery [21]. However, in
this specific case, PAIR could have been
useful only as a first approach to reduce
edema and inflammation.
Since our patient had eight prior
operations with recurrence each time,
perhaps none of these operations was
adequately performed and the post-oper-
ative treatment was not properly instituted
or monitored. The contemporary excision
of all the macroscopic localization, the
careful protection of the surgical field, and
the postoperative administration of me-
bendazole distinguish our intervention
from the eight that preceded it.
The Presenting Case
This report emphasizes the importance
of conservative treatment for a benign
disease like diffuse recurrent hydatidosis.
A muscle- or nerve-sparing attempt should
always be performed and prolonged med-
ical therapy is the mainstay of treatment.
The risk/benefit ratio should always be
analyzed in order to avoid extended
surgical resections that may result in
possible disability. Rare manifestations of
neglected diseases are extremely important,
especially for inexperienced physicians.
Table 1. Patient’s laboratory findings (normal values) at the admission.
White blood cells 12.5610
9/L (4–11.3610
9/L)
Neutrophil percentage 61.9% (41%–73%)
Eosinophil percentage 4.5% (1%–6%)
Red blood cells 5.12610
12/L (4.1–5.9610
12/L)
Hemoglobin 14.70 g/dL (13.5–18 g/dL)
Hematocrit 44.1% (40%–50%)
Alanine aminotransferase 20 U/L (14–63 U/L)
Aspartate aminotransferase 16 U/L (14–45 U/L)
Total bilirubin 0.9 mg/dL (,1.1 mg/dL)
Amylase 178 U/L (4–250 U/L)
Creatine kinase 190 U/L (40–175 U/L)
Lactate deydrogenase 467 U/L (240–450 U/L)
Erythrocyte sedimentation rate 12 mm/h (4–10 mm/h)
doi:10.1371/journal.pntd.0000840.t001
Figure 1. Preoperative basal computed tomography. The involvement
of the psoas muscle and retroperitoneum from the Morrison’s pouch up to
the right iliac fossa and to the iliac region is evident (I, II). The same CT scan
shows the involvement of the right thigh with the cysts localized deeply and
behind the muscular aponeurotic plane of the femoral quadriceps and
abductor muscles up to the knee (III, IV).
doi:10.1371/journal.pntd.0000840.g001
Figure 2. Postoperative computed tomography showing
the outcome of the treatment. The psoas muscle has been
spared despite the resection of the cysts (I, II); the right thigh is
free of cysts with the conservation of the muscular structures
(III, IV).
doi:10.1371/journal.pntd.0000840.g002
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